Mycophenolic Acid: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Mycophenolic Acid. Educational only — not medical advice.
Labeled uses
Mycophenolate mofetil for oral suspension (MMF) is indicated for the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney [see Clinical Studies (14.1) ], heart [see Clinical Studies (14.2) ] or liver transplants [see Clinical Studies (14.3) ] , in combination with other immunosuppressants.
Source: FDA labeling via NIH DailyMed (set 20fa7709…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.